By in Product release

Abbkine Scientific makes another research breakthrough with the launch of the IFKine™ Green Donkey Anti-Goat IgG

Abbkine Scientific makes another research breakthrough with the launch of the IFKine™ Green Donkey Anti-Goat IgGWuhan, China. 430074. 23th March 2017. Abbkine made a major breakthrough with the addition of the Green Donkey Anti-Goat IgG to the IFKine™ family of secondary antibodies. The product is one of the secondary antibodies designed by Abbkine to help with scientific research purposes, available conjugated to biotin, enzyme or even fluorophore, to be used in different antibody-based applications.

IFKine™ Green Donkey Anti-Goat IgG is known can be used in different antibody-based applications like Western Blot, Immunohistochemistry, Immunofluorescence, Flow Cytometry and ELISA thanks to its unique features that include being sourced from the donkey. Its reaction with whole molecule goat IgG and light chains of all other goat immunoglobulins also stands it out from the competition.

A cross-reaction with rat, mouse, human, and guinea pig serum proteins that has been reduced to minimize non-specific hybridization is also another unique feature of the Green Donkey Anti-Goat IgG as well as its sisters in the family.

The Green Donkey Anti-Goat IgG comes in a liquid solution and investigators are advised to determine the optimal working dilutions after series of experiments. However, the suggested starting dilution is put between 1:50 and 1:1,000 for most fluorescent applications.

The benefits of this unique fluoresce staining secondary antibodies include improved brightness, photo stability and less nonspecific hybridization and background. Its donkey host also ensures that the antibody can be used in fluoresce staining, especially in fluoresce multiple labeling.

-MORE-

About Abbkine Scientific

Abbkine Scientific Co. Ltd is a scientific research company founded in 2012 in the United States. Established by a team of scientists and marketing experts, the company moved its headquarters to China to meet up with the growing demand from the Asia Pacific.

The company has been able to combine cutting edge technology from United States and manufacturing engineering and cost advantages from China to provide innovative, high quality assay kits, recombinant proteins, antibodies and other research tools to accelerate life science fundamental research, drug discovery, amongst others.